Regulation of adipose tissue energy availability through blood flow control in the metabolic syndrome

Free Radical Biology and Medicine

Volumn 52, Issue 10, 2012, Pages 2108-2119

  Alemany, Marià ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Blood flow; Blood pressure; Free radicals; Metabolic syndrome; Nitric oxide; Obesity; White adipose tissue

Indexed keywords

ANGIOTENSIN II; CATECHOLAMINE; ENDOTHELIN; LACTIC ACID; NITRIC OXIDE; OXYHEMOGLOBIN; REACTIVE OXYGEN METABOLITE;

ACIDOSIS; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; BLOOD CELL; BLOOD FLOW VELOCITY; BODY DISTRIBUTION; CALORIC INTAKE; CELL DAMAGE; CELL FUNCTION; DEFENSE MECHANISM; ENDOTHELIUM CELL; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; HYPOXEMIA; IMMUNE RESPONSE; INFLAMMATION; LIVER; METABOLIC SYNDROME X; NITROSATIVE STRESS; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ADIPOSE TISSUE; BLOOD FLOW VELOCITY; HUMANS; METABOLIC SYNDROME X; NITRIC OXIDE; OBESITY; OXIDATIVE STRESS; OXYGEN; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; VASOCONSTRICTION;

EID: 84861039296     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.03.003     Document Type: Review

References (236)

1. Crandall, D. L.; DiGirolamo, M. Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations. FASEB J. 4:141-147; 1990.
2. Alexander, J. K.; Dennins, E. W.; Smith, E. W.; Smith, W. G.; Amad, K. H.; Duncan, W. C., et al. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity. Cardiovasc. Res. Cent. Bull. 1:39-44; 1962.
3. Messerli, F. H.; Riise-Sundgaard, K.; Reisin, E.; Dreslinski, G.; Dunn, F. G.; Frolich, E. Disparate cardiovascular effects of obesity and arterial hypertension. Am. J. Med. 74:808-812; 1983.
4. Jansson, P. A. E.; Larsson, A.; Lönnroth, P. N. Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 28:813-818; 1998.
5. Davy, K. P.; Hall, J. E. Obesity and hypertension: two epidemics or one? Am. J. Physiol. 286:R803-R813; 2004.
6. Cinti, S. The adipose organ. Prostaglandins Leukotrienes Essent. Fatty Acids 73:9-15; 2005.
7. Alemany, M.; Fernández-López, J. A. Adipose tissue: something more than just adipocytes. Curr. Nutr. Food Sci. 2:141-150; 2006.
8. Langin, D. In and out: adipose tissue lipid turnover in obesity and dyslipidemia. Cell Metab. 14:569-570; 2011.
9. Malavazos, A. E.; Ermetici, F.; Coman, C.; Corsi, M. M.; Morricone, L.; Ambrosi, B. Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int. J. Cardiol. 121:132-134; 2007.
10. Ichiki, T. Perivascular adipose tissue, a janus-faced regulator of vascular function. Circ. J. 74:1300-1301; 2010.
11. Guzik, T. J.; Marvar, P. J.; Czesnikiewicz-Guzik, M.; Korbut, R. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J. Physiol. Pharmacol. 58:591-610; 2007.
12. Gallagher, D.; Kuznia, P.; Heshka, S.; Albu, J.; Heymsfield, S. B.; Goodpaster, B., et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am. J. Clin. Nutr. 81:903-910; 2005.
13. Melanson, E. L.; Astrup, A.; Donahoo, W. T. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann. Nutr. Metab. 55:229-243; 2009.
14. Zimmermann, M. B.; Aeberli, I. Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review. Int. J. Obes. 32:S11-S18; 2008.
15. Alemany, M. Utilization of dietary glucose in the metabolic syndrome. Nutr. Metab. 8; 2011.
16. Freedland, E.S. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates. Nutr. Metab. 1; 2004.
17. vanDijk, S.J.; Feskens, E.J.M.; Bos,M.B.; Hoelen,D.W.M.; Heijligenberg, R.; Bromhaar,M.G.,etal. A saturated fatty acid-rich diet induces an obesity-linked pro inflammatory gene expression profile in a dipose tissue of subjects at risk of metabolic syndrome. Am. J.Clin.Nutr. 90:1656-1664; 2009.
18. Alemany, M. The defense of a dipose tissue against excess substrate-induced hypertrophia: immune system cell infiltration and arrested metabolic activity. J. Clin. Endocrinol.Metab. 96:66-68; 2011.
19. Cancello, R.; Clément, K. Isobesity an inflammatory illness? Role of low-grade inflammationand macrophage infiltration in human white adipose tissue Br. J.Obstet.Gynaecol. 113:1141-1147; 2006.
20. Subramanian, S.; Han, C.Y.; Chiba, T.; McMillen, T.S.; Wang, S.A.; Haw, A., et al. Dietarycholesterolworsensadiposetissuemacrophageaccumulation and and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28:685-691; 2008.
21. Maury, E.; Brichard, S. M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 314:1-16; 2010.
22. Rajala, M. W.; Scherer, P. E. The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773; 2003.
23. Salmenniemi, U.; Ruotsalainen, E.; Pihlajamäki, J.; Vauhkonen, I.; Kainulainen, S.; Punnonen, K., et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110:3842-3848; 2004.
24. Summers, L. K. M.; Samra, J. S.; Humphreys, S. M.; Morris, R. J.; Frayn, K. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin. Sci. 91:679-683; 1996.
25. West, D. B.; Francendese, A. A.; Greenwood, M. R. C.; Prinz, W. A. Adipocyte blood flow is decreased in obese Zucker rats. Am. J. Physiol. 253:R228-R233; 1987.
26. Muñoz, S.; Franckhauser, S.; Elias, I.; Ferré, T.; Hidalgo, A.; Monteys, A. M., et al. Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia 53:2417-2430; 2010.
27. Qvisth, V.; Hagström-Toft, E.; Sjöberg, M. S.; Bolinder, J. Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am. J. Physiol. 292:E709-E714; 2007.
28. Dijkers, P. F.; O'Farrell, P. H. Dissection of a hypoxia-induced, nitric oxide-mediated signaling cascade. Mol. Biol. Cell 20:4083-4090; 2009.
29. Vigili de Kreutzenberg, E.; Kiwanuka, E.; Tiengo, A.; Avogaro, A. Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur. Heart J. 24:1210-1215; 2003.
30. Hadjipanayi, E.; Brown, R. A.; Mudera, V.; Deng, D.; Liu, W.; Cheema, U. Controlling physiological angiogenesis by hypoxia-induced signaling. J. Controlled Release 146:309-317; 2010.
31. Thatcher, S.; Yiannikouris, F.; Gupte, M.; Cassis, L. The adipose renin-angiotensin system: role in cardiovascular disease. Mol. Cell. Endocrinol. 302:111-117; 2009.
32. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y., et al. A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415; 1988.
33. Loomis, E. D.; Sullivan, J. C.; Osmond, D. A.; Pollock, D. M.; Pollock, J. S. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in rat aorta. J. Pharmacol. Exp. Ther. 315:1058-1064; 2005.
34. Ballard, K.; Cobb, C. A.; Rosell, S. Vascular and lipolytic responses in canine subcutaneous adipose tissue following infusion of catecholamines. Acta Physiol. Scand. 81:246-253; 1971.
35. Millet, L.; Barbe, P.; Lafontan, M.; Berlan, M.; Galitzky, J. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J. Appl. Physiol. 85:181-188; 1988.
36. Korhonen, R.; Lahti, A.; Kankaanranta, H.; Moilanen, E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets inflammation Allergy 4:471-479; 2005.
37. Marchesi, C.; Ebrahimian, T.; Angulo, O.; Paradis, P.; Schiffrin, E. L. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 54:1384-1392; 2009.
38. Williams, I. L.; Wheatcroft, S. B.; Shah, A. M.; Kearney, M. T. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int. J. Obes. 26:754-764; 2002.
39. Frisbee, J. C. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am. J. Physiol. 289:R307-R316; 2005.
40. Hajer, G. R.; van Haeften, T. W.; Visseren, F. L. J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29:2959-2971; 2008.
41. Khanna, D.; Kan, H.; Fang, Q.; Xie, Z.; Underwood, B. L.; Jain, A. C., et al. Inducible nitric oxide synthase attenuates adrenergic signaling in alcohol fed rats. J. Cardiovasc. Pharmacol. 50:692-696; 2007.
42. 2+ current. Am. J. Physiol. 294:H1473-H1480; 2008.
43. Ardilouze, J. L.; Fielding, B. A.; Currie, J. M.; Frayn, K. N.; Karpe, F. Nitric oxide and b-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 109:47-52; 2004.
44. Trayhurn, P.; Wang, B.; Wood, I. S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr. 100:227-235; 2008.
45. Yin, J.; Gao, Z. G.; He, Q.; Zhou, D. Q.; Guo, Z. K.; Ye, J. P. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am. J. Physiol. 296:E333-E342; 2009.
46. Rosdahl, H.; Ungerstedt, U.; Jorfeldt, L.; Henriksson, J. Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis. J. Physiol. 471:637-657; 1993.
47. Feelisch, M.; Fernandez, B. O.; Bryan, N. S.; García-Saura, M. F.; Bauer, S.; Whitlock, D. R., et al. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J. Biol. Chem. 283:33927-33934; 2008.
48. Wolk, R.; Shamsuzzaman, A. S. M.; Somers, V. K. Obesity, sleep apnea, and hypertension. Hypertension 42:1067-1074; 2003.
49. Casado, J.; Fernández-López, J. A.; Esteve, M.; Rafecas, I.; Argilés, J. M.; Alemany, M. Rat splanchnic net oxygen consumption, energy implications. J. Physiol. 431:557-569; 1990.
50. Maniscalco, M.; de Laurentiis, G.; Zedda, A.; Faraone, S.; Giardiello, C.; Cristiano, S., et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir. Physiol. Neurobiol. 156:370-373; 2007.
51. Codoñer-Franch, P.; Tavárez-Alonso, S.; Murria-Estal, R.; Megías-Vericat, J.; Tortajada-Girbés, M.; Alonso-Iglesias, E. Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. Atherosclerosis 215:475-480; 2011.
52. Gil-Ortega, M.; Stucchi, P.; Guzmán-Ruiz, R.; Cano, V.; Arribas, S.; González, M. C., et al. Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity. Endocrinology 151:3299-3306; 2010.
53. Siervo, M.; Jackson, S. J.; Bluck, L. J. C. In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. J. Hypertens. 29:1515-1527; 2011.
54. Sivitz, W. I.; Wayson, S. M.; Bayless, M. L.; Sinkey, C. A.; Haynes, W. G. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction - arterial dysfunction in obesity and diabetes. J. Diabetes Complications 21:149-157; 2007.
55. Stepp, D. W.; Boesen, E. I.; Sullivan, J. C.; Mintz, J. D.; Hair, C. D.; Pollock, D. M. Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am. J. Physiol. 293:H2537-H2542; 2007.
56. Larkin, L. M.; Horwitz, B. A.; Eiffert, K. C.; McDonald, R. B. Adrenergic stimulated skeletal muscle glycogenolysis in perfused hindlimbs of young and old male Fischer-344 rats. Am. J. Physiol. 266:R749-R755; 1994.
57. Smith, U. Adrenergic control of human adipose tissue lipolysis. Eur. J. Clin. Invest. 10:343-344; 1980.
58. Blaak, E. E.; Schiffelers, S. L.; Saris, W. H.; Mensink, M.; Kooi, M. E. Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects. Diabetologia 47:1462-1468; 2004.
59. Foz, M.; Alemany,M.; Gausí, C. Intense muscle fatigue: an undesirable effect of beta blockers use in morbid obesity. Med. Clin. (Barcelona) 116:277-278; 2001.
60. Bender, S. B.; Herrick, E. K.; Lott, N. D.; Klabunde, R. E. Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts. Diabetes Obes. Metab. 9:688-696; 2007.
61. Ardévol, A.; Adán, C.; Remesar, X.; Fernández- López, J. A.; Alemany, M. Hind leg heat balance in obese Zucker rats during exercise. Pflugers Arch. Eur. J. Physiol. 435:454-464; 1998.
62. Pasarica, M.; Sereda, O. R.; Redman, L. M.; Albarado, D. C.; Hymel, D. T.; Roan, L. E., et al. Reduced adipose tissue oxygenation in human obesity - evidence for rarefaction, macrophage chemotaxis, and inflammation without and angiogenic response. Diabetes 58:718-725; 2009.
63. Papapetropoulos, A.; García-Cardeña, G.; Madri, J. A.; Sessa, W. C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:3131-3139; 1997.
64. Solaini, G.; Baracca, A.; Lenaz, G.; Sgarbi, G. Hypoxia and mitochondrial oxidative metabolism. Biochim. Biophys. Acta 1797:1171-1177; 2010.
65. Hosogai, N.; Fukuhara, A.; Oshima, K.; Miyata, Y.; Tanaka, S.; Segawa, K., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911; 2007.
66. Iiyori, N.; Alonso, L. C.; Li, J. G.; Sanders, M. H.; Garcia-Ocana, A.; O'Doherty, R. M., et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med. 175: 851-857; 2007.
67. Klusonová, P.; Reha´ková;, L.; Borchert, G.; Vagnerová, K.; Neckár, J.; Ergang, P., et al. Chronic intermittent hypoxia induces 11b-hydroxysteroid dehydrogenase in rat heart. Endocrinology 150:4270-4277; 2009.
68. Regazzetti, C.; Peraldi, P.; Gremeaux, T.; Najem-Lendom, R.; Ben-Sahra, I.; Cormont, M., et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 58:95-103; 2009.
69. Gess, B.; Schricker, I. K.; Pfeifer, I. M.; Kurtz, A. Acute hypoxia upregulates NOS gene expression in rats. Am. J. Physiol. 273:R905-R910; 1997.
70. Melillo, G.; Musso, T.; Sica, A.; Taylor, L. S.; Cox, G. W.; Varesio, L. A hypoxiare-sponsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1683-1693; 1995.
71. flow, A. J.; Luchsinger, B. P.; Pawloski, J. R.; Singel, D. J.; Stamler, J. S. The oxyhemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. USA 96:9027-9032; 1999.
72. Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 268:4244-4250; 1991.
73. Lummis, S. C. R.; Beene, D. L.; Lee, L. W.; Lester, H. A.; Broadhurst, R. W.; Dougherty, D. A. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438:248-252; 2005.
74. Freeman, B. A.; Baker, P. R. S.; Schopfer, F. J.; Woodcock, S. R.; Napolitano, A.; d'Ischia, M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 283:15515-15519; 2008.
75. Trostchansky, A.; Rubbo, H. Nitrated fatty acids: mechanisms of formation, chemical characterization, and biological properties. Free Radical Biol. Med. 44:1887-1896; 2008.
76. Litchtfield, C.; Harlow, R. D.; Isbell, A. F.; Reiser, R. Cis-trans isomerization of oleic acid by nitrous acid. J. Am. Oil Chem. Soc. 42:73-78; 1965.
77. Proell, J. M.; Mosley, E. E.; flowell, G. L.; Jenkins, T. C. Isomerization of stable isotopically labeled elaidic acid to cis and trans monoenes by ruminal microbes. J. Lipid Res. 43:2072-2076; 2002.
78. van Blitterswijk, W. J.; van der Meer, B. W.; Hilkmann, H. Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity measured by fluorescence polarization. Biochemistry 26:1746-1756; 1987.
79. Zambonin, L.; Ferreri, C.; Cabrini, L.; Prata, C.; Chatgilialoglu, C.; Landi, L. Occurrence of trans fatty acids in rats fed a trans-free diet: a free radical-mediated formation? Free Radical Biol. Med. 40:1549-1556; 2006.
80. Wiswedel, I.; Gardemann, A.; Storch, A.; Peter, D.; Schild, L. Degradation of phospholipids by oxidative stress - exceptional significance of cardiolipin. Free Radical Res. 44:135-145; 2010.
81. Mattson, F. H.; Grundy, S. M. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J. Lipid Res. 26:194-202; 1985.
82. Rode, H. N.; Szamel, M.; Schneider, S.; Resch, K. Phospholipid metabolism of stimulated lymphocytes: preferential incorporation of polyunsaturated fatty acids into plasma membrane phospholipid upon stimulation with concanavalin A. Biochim. Biophys. Acta 688:66-74; 1982.
83. Katan, M. B.; Deslypere, J. P.; van Birgelen, A. P.; Penders, M.; Zegwaard, M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 38:2012-2022; 1997.
84. Kruse, A.; Uehlinger, D.; Gotch, F.; Kotanko, P.; Levin, N. Red blood cell lifespan, erythropoiesis and hemoglobin control. Contrib. Nephrol. 161:247-254; 2008.
85. Satoh, N.; Kotani, K.; Wada, H.; Himeno, A.; Shimada, S.; Sasaki, Y., et al. Unfavorable blood rheology is closely associated with arterial stiffness in obese patients. Endocr. J. 56:915-918; 2009.
86. Cicco, G.; Pirrelli, A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin. Hemorheol. Microcirc. 21:169-177; 1999.
87. Concetti, A.; Massel, P.; Rotilio, G.; Brunori, M.; Rachmilewitz, E. A. Super-oxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with b-thalassemia (major and intermedia). J. Lab. Clin. Med. 87:1057-1064; 1976.
88. Kleinbongard, P.; Schultz, R.; Rassaf, T.; Lauer, T.; Dejam, A.; Jax, T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 107:2943-2951; 2006.
89. McCord, J. M.; Fridovich, I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-6055; 1969.
90. Ulker, P.; Meiselman, H. J.; Baskurt, O. K. Nitric oxide generation in red blood cells induced by mechanical stress. Clin. Hemorheol. Microcirc. 45:169-175; 2010.
91. Thomas, D. The physiology of oxygen delivery. Vox Sang. 87:S70-S73; 2004.
92. Hilpert, P.; Fleischmann, R. G.; Kempe, D.; Bartels, H. The Bohr effect related to blood and erythrocyte pH. Am. J. Physiol. 205:337-340; 1963.
93. Shapiro, R.; Bunn, H. F.; McManus, M. J.; Zalut, C. Sites of non-enzymatic glycosylation of human hemoglobin-A. J. Biol. Chem. 255:3120-3127; 1980.
94. Nathan, D. M.; Kuenen, J.; Borg, R.; Zheng, H.; Schoenfeld, D.; Heine, R. J. Translating the A1C assay into estimated average glucose values. Diabetes Care 31:1473-1478; 2008.
95. Borg, R.; Kuenen, J. HbA1c levels can be expressed as an estimated average glucose (eAG). Clin. Lab. Int. 33:14-61; 2009.
96. Manodori, A. B.; Kuypers, F. A. Altered red cell turnover in diabetic mice. J. Lab. Clin. Med. 140:161-165; 2002.
97. Palou, A.; Remesar, X.; Arola, L.; Alemany, M. Blood and plasma glucose relationships during pregnancy, the breeding cycle and development in the rat. Diabetes Metab. 6:271-275; 1980.
98. Ahmed, N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67:3-21; 2005.
99. Miyashita, Y.; Nishimura, R.; Morimoto, A.; Matsudaira, T.; Sano, H.; Tajima, N. Glycated albumin is flow in obese, type 2 diabetic patients. Diabetes Res. Clin. Pract. 78:51-55; 2007.
100. Roscic, M.; Horvat, S. Transformations of bioactive peptides in the presence of sugars - characterization and stability studies of the adducts generated via the Maillard reaction. Bioorg. Med. Chem. 14:4933-4943; 2006.
101. Fisher, A. B.; Al-Mehdi, A. B.; Manevich, Y. Shear stress and endothelial cell activation. Crit. Care Med. 30:S192-S197; 2002.
102. Azevedo, L. C. P.; Janiszewski, M.; Soriano, F. G.; Laurindo, F. R. M. Redox mechanisms of vascular cell dysfunction in sepsis. Endocr. Metab. Immune Disord. Drug Targets 6:159-164; 2006.
103. Nikolaidis,M. G.; Jamustas, A. Z. Blood as a reactive species generator and redox status regulator during exercise. Arch. Biochem. Biophys. 490:77-84; 2009.
104. Senault, C.; Yazbeck, J.; Goubern, M.; Portet, R.; Vincent, M.; Gallay, J. Relation between membrane phospholipid composition, fluidity and function in mitochondria of rat brown adipose tissue: effect of thermal adaptation and essential fatty acid deficiency. Biochim. Biophys. Acta 1023:283-289; 1990.
105. Kabagambe, E. K.; Tsai, M. Y.; Hopkins, P. N.; Ordovas, J. M.; Peacock, J. M.; Borecki, I. B., et al. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin. Chem. 54:154-162; 2008.
106. Parks, E. J.; German, J. B.; Davis, P. A.; Frankel, E. N.; Kappagoda, C. T.; Rutledge, J. C., et al. Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am. J. Clin. Nutr. 68:778-785; 1998.
107. Vidgren, H. M.; Ågren, J. J.; Schwab, U.; Rissanen, T.; Hänninen, O.; Uusitupa, M. I. J. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32:697-705; 1997.
108. Chen, J. J.; Yu, B. P. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radical Biol. Med. 17:411-418; 1994.
109. Wood, J.; Garthwaite, J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 33:1235-1244; 1994.
110. Przedborski, S.; Ischiropoulos, H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signaling 7:685-693; 2005.
111. Zielonka, J.; Sikora, A.; Joseph, J.; Kalyanaraman, B. Peroxynitrite is the major species formed from different flux ratios of co-generated nitric oxide and superoxide: direct reaction with boronate-based fluorescent probe. J. Biol. Chem. 285:14210-14216; 2010.
112. Lavi, S.; Yang, E. H.; Prasad, A.; Mathew, V.; Barsness, G. W.; Rihal, C. S., et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 51:127-133; 2008.
113. Mouren, S.; Souktani, R.; Beaussier, M.; Abdenour, L.; Arthaud, M.; Duvelleroy, M., et al. Mechanisms of coronary vasoconstriction induced by high arterial oxygen tension. Am. J. Physiol. 272:H67-H75; 1997.
114. Félétou, M.; Huang, Y.; Vanhoutte, P. M. Vasoconstrictor prostanoids. Pflügers Arch. Eur. J. Physiol. 459:941-950; 2010.
115. Gao, Y. J.; Takemori, K.; Su, L. Y.; An, W. S.; Lu, C.; Sharma, A. M., et al. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc. Res. 71:363-373; 2006.
116. 1-adrenergic vasoconstriction in the regulation of skeletal muscle blood flow with advancing age. Am. J. Physiol. 296:H497-H504; 2009.
117. Zhou, Y. T.; Grayburn, P.; Karim, A.; Shimabukuro, M.; Higa, M.; Baetens, D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U S A 97:1784-1789; 2000.
118. Gruberg, L.; Weissman, N. J.; Waksman, R.; Fuchs, S.; Deible, R.; Pinnow, E. E., et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J. Am. Coll. Cardiol. 39:578-584; 2002.
119. Jebelovszki, E.; Kiraly, C.; Erdei, N.; Feher, A.; Pasztor, E. T.; Rutkai, I., et al. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am. J. Physiol. 294:H2558-H2564; 2008.
120. Turhan, H.; Erbay, A. R.; Yasar, A. S.; Bicer, A.; Sasmaz, H.; Yetkin, E. Impaired coronary blood flow in patients with metabolic syndrome: documented by thrombolysis in myocardial infarction (TIMI) frame count method. Am. Heart J. 148:789-794; 2004.
121. 2+]i signaling. Am. J. Physiol. 290:R145-R153; 2006.
122. Barton, M.; Carmona, R.; Ortmann, J.; Krieger, J. E.; Traupe, T. Obesityassociated activation of angiotensin and endothelin in the cardiovascular system. Int. J. Biochem. Cell Biol. 35:826-837; 2003.
123. Tamarat, R.; Silvestre, J. S.; Durie, M.; Levy, B. I. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation- related pathways. Lab. Invest. 82:747-756; 2002.
124. Saint-Marc, P.; Kozak, L. P.; Ailhaud, G.; Darimont, C.; Negrel, R. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 142:487-492; 2001.
125. Knerr, I.; Schirl, C.; Horbach, T.; Stuppy, A.; Carbon, R.; Rascher, W., et al. Maturation of the expression of adrenomedullin, endothelin-1 and nitric oxide synthases in adipose tissues from childhood to adulthood. Int. J. Obes. 29:275-280; 2005.
126. van Harmelen, V.; Eriksson, A.; Åström, G.; Wåhlén, K.; Näslund, E.; Karpe, F., et al. Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 57:378-386; 2008.
127. Basili, S.; Pacini, G.; Guagnano, M. T.; Manigrasso, M. R.; Santilli, F.; Pettinella, C., et al. Insulin resistance as a determinant of platelet activation in obese women. J. Am. Coll. Cardiol. 48:2531-2538; 2006.
128. Schneider, D. J. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron. Artery Dis. 16:473-476; 2005.
129. Lundberg, J. O.; Weitzberg, E.; Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discovery 7:156-167; 2008.
130. Torres, J.; Sharpe, M. A.; Rosquist, A.; Cooper, C. E.; Wilson, M. T. Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Lett. 475:263-266; 2000.
131. Garnier, M.; Attali, J. R.; Valensi, P.; Delatour-Hanss, E.; Gaudey, F.; Houtsouris, D. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 39:794-798; 1990.
132. Simpson, L. O. Altered blood rheology in the pathogenesis of diabetic and other neuropathies. Muscle Nerve 11:725-744; 1988.
133. Cinara, L.; Bollini, A.; Gayol, M. C.; Hernández, G. N. In vitro effect of insulin on rats erythrocytes rheological behaviour. Clin. Hemorheol. Microcirc. 35:367-373; 2006.
134. Marcelin, G.; Chua, S. Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity. Curr. Opin. Pharmacol. 10:588-593; 2010.
135. Stich, V.; de Glisezinski, I.; Berlan, M.; Bulow, J.; Galitzky, J.; Harant, I., et al. Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise. J. Appl. Physiol. 88:1277-1283; 2000.
136. Fredholm, B. B.; Karlsson, J. Metabolic effects of prolonged sympathetic nerve stimulation in canine subcutaneous adipose tissue. Acta Physiol. Scand. 80:567-576; 1970.
137. + effluxes from human skeletal muscles during intense, dynamic exercise. J. Physiol. 462:115-133; 1993.
138. Andersson, K.; Gaudiot, N.; Ribiere, C.; Elizalde, M.; Giudicelli, Y.; Arner, P. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br. J. Pharmacol. 126:1639-1645; 2009.
139. Marina Morales, L.; Campos, G.; Ryder, E.; Casanova, A. Insulin and lipogenesis in rat adipocytes. II. Effect of high levels of insulin and glucose on lipid synthesis in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 199:1151-1157; 1994.
140. DiGirolamo, M.; Newby, F. D.; Lovejoy, J. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J. 6:2405-2412; 1992.
141. Hagström, E.; Arner, P.; Ungerstedt, U.; Bolinder, J. Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am. J. Physiol. 258:E888-E893; 1990.
142. Geelen, M. J. H.; Hindriks, G. A. Studies on the substrate for hepatic lipogenesis in the rat. FEBS Lett. 175:8-12; 1984.
143. McDaniel, H. G. Acute suppression of hepatic gluconeogenesis by glucose in the intact animal. Am. J. Physiol. 229:1569-1575; 1975.
144. Crandall, D. L.; Hausman, G. J.; Kral, J. G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4:211-232; 1997.
145. Kunduzova, O.; Alet, N.; Delesque-Touchard, N.; Millet, L.; Castan-Laurell, I.; Muller, C., et al. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J. 22:4146-4153; 2008.
146. Voros, G.; Maquoi, E.; Demeulemeester, D.; Clerx, N.; Collen, D.; Lijnen, H. R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146:4545-4554; 2005.
147. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:1752-1761; 2004.
148. Roberts, C. K.; Sindhu, K. K. Oxidative stress and metabolic syndrome. Life Sci. 84:705-712; 2009.
149. van Guilder, G. P.; Hoetzer, G. L.; Greiner, J. J.; Stauffer, B. L.; DeSouza, C. A Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 14:2217-2231; 2006.
150. Moldovan, L.; Moldovan, N. I. Oxygen free radicals and redox biology of organelles. Histochem. Cell Biol. 122:395-412; 2004.
151. 2+ through uncoupling proteins. Antioxid. Redox Signaling 11:1805-1818; 2009.
152. Negre-Salvayre, A.; Hirtz, C.; Carrera, G.; Cazenave, R.; Troly, M.; Salvayre, R., et al. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11:809-815; 1997.
153. Bohr, C.; Hasselbalch, K.; Krogh, A. Über einen in biologischer Beziehung wichtigen Einfluss, den die Kohlensäurespannung des Blutes auf dessen Sauerstoffbindungübt. Scand. Arch. Physiol. 16:402-412; 1904.
154. Murphy, M. P. flow mitochondria produce reactive oxygen species. Biochem. J. 417:1-13; 2009.
155. Chen, B. Y.; Lam, K. S. L.; Wang, Y.; Wu, D. H.; Lam, M. C.; Shen, J. G., et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem. Biophys. Res. Commun. 341:549-556; 2006.
156. Hopps, E.; Noto, D.; Caimi, G.; Averna, M. R. A novel component of the metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovasc. Dis. 20:72-77; 2010.
157. White, P. J.; Charbonneau, A.; Cooney, G. J.; Marette, A. Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species. Am. J. Physiol. 299:E868-E878; 2010.
158. Gregor, M. F.; Hotamisligil, G. S. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res. 48:1905-1914; 2007.
159. Villaret, A.; Galitzky, J.; Decaunes, P.; Esteve, D.; Marques, M. A.; Sengenes, C., et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59:2755-2763; 2010.
160. Korantzopoulos, P.; Kokkoris, S.; Papaioannides, D. The association of metabolic syndrome with atrial fibrillation: an emerging epidemiological and pathophysiological hypothesis. Cardiology 104:148-149; 2005.
161. Nicholls, G. A.; Reinier, K.; Chugh, S. S. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 32:1851-1856; 2009.
162. Chasens, E. R.; Weaver, T. E.; Umlauf, M. G. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link? Biol. Res. Nurs. 5:87-96; 2003.
163. Vanderschueren, D.; Vandenput, L.; Boonen, S.; Lindberg, M. K.; Bouillon, R.; Ohlsson, C. Androgens and bone. Endocr. Rev. 25:389-425; 2004.
164. Vgontzas, A. N.; Papanicolaou, D. A.; Bixler, E. O.; Hopper, K.; Lotsikas, A.; Lin, H. M., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab. 85:1151-1158; 2000.
165. Amra, B.; Karbasi, E.; Hashemi, M.; Hoffmann-Castendiek, B.; Golshan, M. Endothelial dysfunction in patients with obstructive sleep apnoea independent of metabolic syndrome. Ann. Acad. Med. Singapore 38:461-464; 2009.
166. Dicker, A.; Cannon, B.; Nedergaard, J. Stimulation of nonshivering thermo-genesis in the Syrian hamster by norepinephrine and β-selective adrenergic agents: a phenomenon of refractoriness. Comp. Biochem. Physiol. 113C:37-43; 1996.
167. Wong, D. L.; Tai, T. C.; Wong-Faull, D. C.; Claycomb, R.; Kvetnansky, R. Adrenergic responses to stress - transcriptional and post-transcriptional changes. Ann. N. Y. Acad. Sci. 1148:249-256; 2008.
168. Sapolsky, R. M.; Romero, L. M.; Munck, A. U. flow do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocr. Rev. 21:53-89; 2000.
169. Scheuer, D. A. Regulation of the stress response in rats by central actions of glucocorticoids. Exp. Physiol. 95:26-31; 2010.
170. Harris, W. S.; Schoenfield, C. D.; Weissler, A. M. Effects of adrenergic receptor activation and blockade on the systolic projection period, heart rate, and arterial pressure in man. J. Clin. Invest. 46:1704-1714; 1967.
171. Loot, A. E.; Schreiber, J. G.; Fisslthaler, B.; Fleming, I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J. Exp. Med. 206:2889-2896; 2009.
172. Gladwin, M. T.; Crawford, J. H.; Patel, R. P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radical Biol. Med. 36:707-717; 2004.
173. Breuer, H. W. M.; Skyschally, A.; Schulz, R.; Martin, C.; Wehr, M.; Heusch, G. Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers. Br. Heart J. 70:144-149; 1993.
174. Hanada, A.; Sander, M.; González-Alonso, J. Human skeletal muscle sympathetic nerve activity, heart rate and limb haemodynamics with reduced blood oxygenation and exercise. J. Physiol. 551:635-647; 2003.
175. Jakicic, J. M.; Donnelly, J. E.; Pronk, N. P.; Jawad, A. F.; Jacobsen, D. J. Prescription of exercise intensity for the obese patient: the relationship between heart rate, VO2 and perceived exertion. Int. J. Obes. 19:382-387; 1995.
176. Gustafson, A. B.; Kalkhoff, R. K. Influence of sex and obesity on plasma catecholamine response to isometric exercise. J. Clin. Endocrinol. Metab. 55:703-708; 1982.
177. Allessie, M. A.; Boyden, P. A.; Camm, A. J.; Kléber, A. G.; Lab, M. J.; Legato, M. J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103:769-777; 2001.
178. Schauerte, P.; Scherlag, B. J.; Patterson, E.; Scherlag, M. A.; Matsudaria, K.; Nakagawa, H., et al. Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomous nervous system. J. Cardiovasc. Electrophysiol. 12:592-599; 2001.
179. Pagano, C.; Calcagno, A.; Granzotto, M.; Calabrese, F.; Thiene, G.; Federspil, G., et al. Heart lipid accumulation in obese non-diabetic rats: effect of weight loss. Nutr. Metab. Cardiovasc. Dis. 18:189-197; 2008.
180. Young, M. E.; Guthrie, P. H.; Razeghi, P.; Leighton, B.; Abbasi, S.; Patil, S., et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51:2587-2595; 2002.
181. Christoffersen, C.; Bollano, E.; Lindegaard, M. L. S.; Bartels, E. D.; Goetze, J. P.; Andersen, C. B., et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144:3483-3490; 2003.
182. Koch, R.; Sharma, A. M. Obesity and cardiovascular hemodynamic function. Curr. Hypertens. Rep. 1:127-130; 1999.
183. Wiewiora, M.; Sosada, K.; Wylezol, M.; Slowinska, L.; Zurawinski, W. Red blood cell aggregation and deformability among patients qualified for bariatric surgery. Obes. Surg. 17:365-371; 2007.
184. Chaowalit, N.; Somers, V. K.; Pellikka, P. A.; Rihal, C. S.; Lopez-Jimenez, F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186:354-359; 2006.
185. Zhou, Y. A.; Wei, Y. T.; Wang, L.; Wang, X. G.; Du, X. L.; Sun, Z. Q., et al. Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease. Cardiovasc. Diabetol. 10; 2011.
186. Iacobellis, G.; Sharma, A. M. Epicardial adipose tissue as new cardiometabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr. Pharm. Des. 13:2180-2184; 2007.
187. Wang, C. P.; Hsu, H. L.; Hung, W. C.; Yu, T. H.; Chen, Y. H.; Chiu, C. A., et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin. Endocrinol. 70:876-882; 2009.
188. Parish, J. M.; Somers, V. K. Obstructive sleep apnea and cardiovascular disease. Mayo Clin. Proc. 79:1036-1046; 2004.
189. Dempsey, J. A.; Veasey, S. G.; Morgan, B. J.; O'Donnell, C. P. Pathophysiology of sleep apnea. Physiol. Rev. 90:47-112; 2010.
190. Redline, S.; Strohl, K. P. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin. Chest Med. 19:1-19; 1998.
191. Vanninen, E.; Tuunainen, A.; Kansanen, M.; Uusitupa, M.; Lansimies, E. Cardiac sympathovagal balance during sleep apnea episodes. Clin. Physiol. 16:209-216; 1996.
192. Needleman, M.; Calkins, H. The role of obesity and sleep apnea in atrial fibrillation. Curr. Opin. Cardiol. 26:40-45; 2011.
193. Kapsimalis, F.; Basta, M.; Varouchakis, G.; Gorgoulianis, K.; Vgontzas, A.; Kryger, M. Cytokines and pathological sleep. Sleep Med. 9:603-614; 2008.
194. Olopade, C. O.; Christon, J. A.; Zakkar, M.; Hua, C. W.; Swedler, W. I.; Scheff, P. A., et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111:1500-1504; 1997.
195. Ip, M. S. M.; Chan, L. Y.; Zheng, L.; Tsang, K. W. T.; Fung, P. C. W.; Lam, W. K. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med. 162:2166-2171; 2000.
196. Beuther, D. A. Obesity and asthma. Clin. Chest Med. 30:479-488; 2009.
197. Shore, S. A. Obesity and asthma: possible mechanisms. J. Allergy Clin. Immunol. 121:1087-1093; 2008.
198. Marshall, G. D.; Agarwal, S. K. Stress immune regulation, and immunity: applications for asthma. Allergy Asthma Proc. 21:241-246; 2000.
199. Umetsu, D. T.; McIntire, J. J.; Akbari, O.; Macaubas, C.; DeKruyff, R. H. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720; 2002.
200. Rosell, S.; Belfrage, E. Adrenergic receptors in adipose tissue and their relation to adrenergic innervation. Nature 253:738-739; 1975.
201. Levin, B. E.; Triscari, J.; Sullivan, A. C. Altered sympathetic activity during development of diet-induced obesity in rat. Am. J. Physiol. 244:R347-R355; 1983.
202. Hjemdahl, P.; Fredholm, B. B. Influence of acidosis on noradrenalineinduced vasoconstriction in adipose tissue and skeletal muscle. Acta Physiol. Scand. 97:319-324; 1976.
203. Henriksen, O.; Nielsen, S. L.; Paaske, W. Intrinsic regulation of blood flow in adipose tissue. Acta Physiol. Scand. 98:30-36; 1976.
204. Karpe, F.; Fielding, B. A.; Ardilouze, J. L.; Macdonald, I. A.; Frayn, K. N. Effects of insulin on adipose tissue blood flow in man. J. Physiol. 540:1087-1093; 2002.
205. Ye, J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. 33:54-66; 2009.
206. Karpe, F.; Fielding, B. A.; Ilic, V.; Macdonald, I. A.; Summers, L. K. M.; Frayn, K. N. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 51:2467-2473; 2002.
207. Rickett, G. M. W.; Kelly, F. J. Developmental expression of antioxidant enzymes in guinea pig lung and liver. Development 108:331-336; 1990.
208. Ardévol, A.; Adán, C.; Remesar, X.; Alemany, M.; Fernández-López, J. A. Muscle blood flow during intense exercise in the obese rat. Arch. Physiol. Biochem. 104:337-343; 1996.
209. Vaarala, O.; Atkinson, M. A.; Neu, J. The ''perfect storm'' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555-2562; 2008.
210. Eitzman, D. T.; Westrick, R. J.; Xu, Z. J.; Tyson, J.; Ginsburg, D. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:1831-1834; 2000.
211. Podrez, E. A.; Byzova, T. V.; Febbraio, M.; Salomon, R. G.; Valiyaveettil, M.; Poliakov, E., et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 13:1086-1095; 2007.
212. Steinhubl, S.; Moliterno, D. J. The role of the platelet in the pathogenesis of atherothrombosis. Am. J. Cardiovasc. Drugs 5:399-408; 2005.
213. Guzik, T. J.; Mangalat, D.; Korbut, R. Adipocytokines-novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57:505-528; 2006.
214. Grant, P. J. Inflammatory, atherothrombotic aspects of type 2 diabetes. Curr. Med. Res. Opin. 21:S5-S12; 2005.
215. Blanco, M.; Rodríguez-Yáñez, M.; Sobrino, T.; Leira, R.; Castillo, J. Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction. Cerebrovasc. Dis. 20:32-39; 2005.
216. Eriksson, J. W. Metabolic stress in insulin's target cells leads to ROS accumulation-a hypothetical common pathway causing insulin resistance. FEBS Lett. 581:3734-3742; 2007.
217. Weber, T.; Auer, J.; O'Rourke, M. F.; Kvas, E.; Lassing, E.; Berent, R., et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184-189; 2004.
218. Thubrikar, M. J.; Robicsek, F. Pressure-induced arterial wall stress and atherosclerosis. Ann. Thorac. Surg. 59:1594-1603; 1995.
219. Tuzcu, E. M.; Kapadia, S. R.; Tutar, E.; Ziada, K. M.; Hobbs, R. E.; McCarthy, P. M., et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103:2705-2710; 2001.
220. Dandona, P.; Aljada, A.; Chaudhuri, A.; Mohanty, P.; Garg, R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 111:1448-1454; 2005.
221. de la Cruz, C. S.; Matthay, R. A. Role of obesity in cardiomyopathy and pulmonary hypertension. Clin. Chest Med. 30:509-523; 2009.
222. Messerli, F. H. Cardiovascular effects of obesity and hypertension. Lancet 319:1165-1168; 1982.
223. Ailhaud, G.; Massiera, F.; Weill, P.; Legrand, P.; Alessandri, J. M.; Guesnet, P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog. Lipid Res. 45:203-236; 2006.
224. Micallef, M.; Munro, I.; Phang, M.; Garg, M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br. J. Nutr. 102: 1370-1374; 2009.
225. Matsubara, M.; Maruoka, S.; Katayose, S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur. J. Endocrinol. 147:173-180; 2002.
226. Zou, C. C.; Liang, L.; Hong, F. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Indian Pediatr. 44:275-279; 2007.
227. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat. Med. 8:731-737; 2002.
228. Dai, Z.; Zhu, H. Q.; Jiang, D. J.; Jiang, J. L.; Deng, H. W.; Li, Y. J. 17β-Estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Int. J. Cardiol. 96:223-227; 2004.
229. Chevalier, S.; Marliss, E. B.; Morais, J. A.; Lamarche, M.; Gougeon, R. Wholebody protein anabolic response is resistant to the action of insulin in obese women. Am. J. Clin. Nutr. 82:355-365; 2005.
230. Duclos, M.; Pereira, P. M.; Barat, P.; Gatta, B.; Roger, P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes. Res. 13:1157-1166; 2005.
231. Erlingsson, S.; Herard, S.; Leinhard, O. D.; Lindström, T.; Länne, T.; Borga, M., et al. Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women. Metabolism 58:995-1001; 2009.
232. Hong, J.; Stubbins, R. E.; Smith, R. R.; Harvey, A. E.; Núñez, N. P. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr. J. 8:11; 2009.
233. Faustini-Fustini, M.; Rochira, V.; Carani, C. Oestrogen deficiency in men: where are we today. Eur. J. Endocrinol. 140:111-129; 1999.
234. You, T. J.; Ryan, A. S.; Nicklas, B. J. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J. Clin. Endocrinol. Metab. 89:5517-5522; 2004.
235. Vachharajani, V.; Granger, D. N. Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life 61:424-430; 2009.
236. Alemany, M. The problem of nitrogen disposal in the obese. Nutr. Res. Rev, http://dx.doi.org/10.1017/S0954422411000163, in press.